Skip to main content
Science
Clinical Trials
Guide to Clinical Trials
Clinical Trials in Children
Data and Results
Integrity and Transparency
Diversity
Plain Language Study Results
Expanded Access & Compassionate Use
Find a Trial
Areas of Focus
Rare Disease
Internal Medicine
Inflammation & Immunology
Vaccines
Oncology
Anti Infectives
Areas of Innovation
Medicinal Sciences
Precision Medicine
Maternal Immunization
mRNA Technology
Diseases & Conditions
Coronavirus Resources
Product Pipeline
Research Sites
Products
How Drugs are Made
Branded vs. Generic
Biologics & Biosimilars
Commitment to Quality
Global Supply
Manufacturing Sites
Medicine Safety
Health Literacy
Treatment Choices
Partnering With Patients
Tips for Patients
Reporting Adverse Events
Counterfeiting
Product Safety
Product List
Product Contacts
PfizerPro for Professionals
Patient Assistance Programs
Distributors
Pfizer Distributors
Stories
Articles
Announcements
Behind the Science Features
Podcasts
eBooks
Newsroom
Press Releases
Media Asset Library
Updates and Statements
Partnering News
Media Contacts
About
People
Executives
Board Members
Scientists
Patient Stories
Colleague Stories
Responsibility
Ethics & Compliance
Responsible Business
Patient Advocacy & Engagement
Global Impact
Diversity, Equity, and Inclusion
Environmental Sustainability
Human Rights
Health & Safety
Intellectual Property
EHS Governance
Misinformation
Programs & Policies
Grants
Political Partnership
Working with Healthcare Professionals
Prescription Value & Pricing
Privacy Principles
Ready for Cures
Transparency in Grants
Policy Positions
Corporate Governance
Corporate Governance Overview
Board Committees & Charters
The Pfizer Board Policies
Corporate Governance FAQs
Contact Our Directors
Purpose
History
Careers
Partners
Research and Business Development Partnerships
Venture Investments
Business to Business
Pfizer CentreOne
Pfizer Ignite
Submit Your Opportunities
Contact Us
Careers
Investors
Search
Contact Us
Hamburger
Changed
Changed
How can we help you?
0
search results for
Suggestions within Pfizer.com
Header close
Header close
Home
Newsroom
Press Releases
Press Releases
Filter Options
Archive Date
Year
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Month
January
February
March
April
May
June
July
August
September
October
November
December
View 12
View 12
View 24
View 48
Categories
Corporate
Financial
Prescription Medicines
Research and Pipeline
Social Responsibility
Vaccines
Keywords
All Keywords
Covid-19
Finance
Investments
Leadership
Medicines
Partnerships
Research
Responsibility
Vaccines
April 2016
04.26.2016
Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled
04.22.2016
CHANTIX®/CHAMPIX® (varenicline) Results from the Largest Global Clinical Trial of Smoking Cessation Medicines Published in The Lancet
04.21.2016
Pfizer Invites Public to Listen to Webcast of April 28 Annual Meeting of Shareholders
04.19.2016
Partnerships
AM-Pharma STOP-AKI Phase II trial nominated for “Most Innovative Clinical Trial Design” in 2016 CARE Awards
04.19.2016
Pfizer Announces Positive Top-Line Results for Phase 3 PALOMA-2 Clinical Trial of IBRANCE® (palbociclib)
04.07.2016
Pfizer Taps IBM for Research Collaboration to Transform Parkinson’s Disease Care
04.06.2016
Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®
04.06.2016
Pfizer Announces Termination of Proposed Combination with Allergan
04.05.2016
FDA Approves INFLECTRA™ (Biosimilar Infliximab), The First U.S. Biosimilar Monoclonal Antibody, For All Eligible Indications
04.05.2016
Merck and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinom
04.05.2016
Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Psoriatic Arthritis
04.04.2016
Pfizer and Allergan Issue Statement
Page
91
Page
92
Current page
93
Page
94
Page
95
Cookies Preference